A new strategy to beat lung cancer: Chemists develop first-in-class inhibitor targeting a key epigenetic regulator
by The University of Hong Kong edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Tumor suppression in vivo. In animal models, LS-170 treatment significantly reduced tumor volume, demonstrating its strong anti-cancer potential. Credit: Nature Chemical Biology (2026). DOI: 10.1038/s41589-025-02132-7 A research team has made a breakthrough in epigenetic drug discovery. The researchers […]
